Rankings
▼
Calendar
TARA FY 2015 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$212M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$57,000
Operating Income
-$21M
Net Income
-$21M
EPS (Diluted)
$-51.94
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$68M
Total Liabilities
$4M
Stockholders' Equity
$63M
Cash & Equivalents
$40M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$3M
-100.0%
Gross Profit
-$57,000
$3M
-101.9%
Operating Income
-$21M
-$8M
-175.3%
Net Income
-$21M
-$3M
-539.6%
← FY 2014
All Quarters
Q4 2015 →